Invicta Diagnostic Limited IPO
Invicta Diagnostics Limited, operating under the brand “PC Diagnostics”, is a diagnostic chain in the Mumbai Metropolitan Region (MMR) offering radiology and pathology services. The company provides imaging solutions, clinical laboratory testing, and teleradiology services through a digitally driven model focused on accessibility, affordability, and quality customer care.
Business Model & Customer Base
The company operates predominantly in the B2C segment, with ~87% of revenue generated from individual patients in FY25. The strategy focuses on:
1. Direct customer engagement
2. Affordable one-stop diagnostics under one roof
3. Home collection and digital access to reports
Products & Services
Invicta offers a diverse diagnostic portfolio with:
i) ~60 routine and 487 specialized pathology tests
ii) ~96 basic and ~130 advanced radiology tests
Services range from basic tests such as X-rays, Ultrasounds, ECGs to advanced modalities like MRI, CT Scan, and PET-CT, supported with home collection and digital reporting to enhance patient convenience.
Operational Network
Invicta follows a Hub-and-Spoke model, ensuring centralized quality control and wider reach. As of September 30, 2025, the network includes:
– 1 flagship centre (main hub) in Thane
– 3 hub centres (with MRI/CT/PET-CT)
– 3 spoke centres for basic testing and sample collection
– 1 centralized laboratory
The diagnostic services are managed by a professional team comprising 20 radiologists, 4 laboratory doctors, and 133 technical staff.
Market Opportunity & Growth Outlook
The Indian diagnostics industry has experienced strong growth driven by ageing population, rising non-communicable diseases, medical tourism, and urbanization. Radiology holds a significant share of India’s diagnostic market and is projected to expand at a ~13.5% CAGR through 2030, presenting a strong opportunity for Invicta’s radiology-led business expansion.
Objects of the Invicta Diagnostic Limited IPO:
Invicta Diagnostic Limited IPO Details:
| Open Date: | Dec 01 2025 |
| Close Date: | Dec 03 2025 |
| Total Shares: | 33,08,800 |
| Face Value: | ₹ 10 Per Equity Share |
| Issue Type: | Book Builidng |
| Issue Size: | 28.12 Cr. |
| Lot Size: | 1600 Shares |
| Issue Price: | ₹ 80 - 85 Per Equity Share |
| Listing At: | NSE Emerge |
| Listing Date: | Dec 08 2025 |
Promoters And Management:
Financials of Invicta Diagnostic Limited IPO:
| Particulars | 6M FY2025-26 | FY 2024-25 | FY 2023-2024 |
| Revenue from Operations (Cr) | 16.94 | 30.09 | 15.83 |
| EBITDA (Cr) | 6.76 | 9.19 | 7.08 |
| EBITDA Margins | 39.92% | 30.57% | 44.77% |
| PAT (Cr) | 4.08 | 4.92 | 3.8 |
| PAT Margins | 24.10% | 16.38% | 24.04% |
| ROCE | 22.80% | 42.00% | 56.04% |
| OPerating Cash Flow | 5.01 | 6.55 | 6.36 |
| Debt to Equity Ratio(In Times) | 0.16 | 0.26 | 0.44 |
Comparison With Peers:
| Companies | Revenue (in cr) | EBITDA Margins | PAT Margins | ROCE | D/E Ratio | MCap (in cr) | P/E |
| Invicta Diagnostic Limited | 30.09 | 30.57% | 16.38% | 42.00% | 0.26 | 106.86 | 21.72 |
| Vijaya Diagnostic Centre Limited | 681 | 40% | 21% | 20.90% | 0.42 | 10295 | 67.50 |
| Krsnaa Diagnostics Limited | 682 | 29% | 12% | 13% | 0.3 | 2628 | 30.8 |
| NOTE:Forward P/E is 13.09 According to FY 2026 PAT | |||||||
Lead Manager of Invicta Diagnostic Limited IPO:
Registrar of Invicta Diagnostic Limited IPO:
Discussion on Invicta Diagnostic Limited IPO:
Leave a Reply
You must be logged in to post a comment.